| Literature DB >> 30081555 |
Ping Liu1, Jiao Xue2, Shisheng Tong3, Wenxia Dong4, Peipei Wu5.
Abstract
In the present study, two polysaccharides (HIOP1-S and HIOP2-S) were isolated and purified from Inonotus obliquus using DEAE-52 cellulose and Sephadex G-100 column chromatography. The structural characterization and in vitro and in vivo hypoglycaemic activities of these molecules were investigated. HPLC analysis HIOP1-S was a heterpolysaccharide with glucose and galactose as the main compontent monosaccharides (50.247%, molar percentages). However, HIOP2-S was a heterpolysaccharide with glucose as the main monosaccharide (49.881%, molar percentages). The average molecular weights of HIOP1-S and HIOP2-S were 13.6 KDa and 15.2 KDa, respectively. The β-type glycosidic bond in HIOP1-S and HIOP2-S was determined using infrared analysis. ¹H-NMR spectra indicated that HIOP2-S contains the β-configuration glycosidic bond, and the glycoside bonds of HIOP1-S are both α-type and β-type. The ultraviolet scanning showed that both HIOP1-S and HIOP2-S contained a certain amount of binding protein. Congo red test showed that HIOP1-S and HIOP2-S could form a regular ordered triple helix structure in the neutral and weakly alkaline range. HIOP1-S and HIOP2-S showed strong α-glucosidase inhibitory activities and increased the glucose consumption of HepG2 cells. In addition, Streptozotocin (STZ)-induced hyperglycaemic mice were used to evaluate the antihyperglycaemic effects of HIOP1-S and HIOP2-S in vivo. The results showed that HIOP2-S had antihyperglycaemic effects. Taken together, these results suggest that HIOP1-S and HIOP2-S have potential anti-diabetic effects.Entities:
Keywords: HepG2 cells; Inonotus obliquus; polysaccharide; structure; α-glucosidase inhibitory activity
Mesh:
Substances:
Year: 2018 PMID: 30081555 PMCID: PMC6222507 DOI: 10.3390/molecules23081948
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(A) Sephadex G-100 column chromatography for HIOP1-S; (B) Sephadex G-100 column chromatography for HIOP2-S.
Figure 2(A) The GPC gel chromatography spectrum of HIOP1-S; (B) The GPC gel chromatography spectrum of HIOP2-S.
Monosaccharide composition and percentage.
| Sample | HIOP1-S (%) | HIOP2-S (%) |
|---|---|---|
| Carbohydrate | 82.73 ± 3.01 a | 84.62 ± 1.09 a |
| Protein | 1.79 ± 0.74 a | 1.93 ± 0.32 a |
| Uronic acid | 9.98 ± 1.34 a | 11.45 ± 0.98 a |
| Mannose | 1.75 | 9.714 |
| Rhamnose | 12.233 | 15.331 |
| Glucose | 29.673 | 49.881 |
| Galactose | 20.547 | 15.321 |
| Xylose | 2.386 | 4.675 |
| Arabinose | 15.786 | 5.078 |
| Fucose | 17.626 | - |
Means ± S.D.; a p > 0.05 HIOP1-S vs. HIOP2-S.
Figure 3(A) Fourier transform infrared spectroscopy of HIOP1-S; (B) Fourier transform infrared spectroscopy of HIOP2-S.
Figure 41H-NMR spectrum (A) HIOP1-S; (B) HIOP2-S.
Figure 5UV absorption spectra of HIOP1-S and HIOP2-S.
Figure 6Congro Red test of HIOP1-S and HIOP2-S.
The IC50 of H1OP1-S and H1OP2-S.
| Polysaccharides | IC50 (µg/mL) |
|---|---|
| HIOP1-S | 7.875 |
| HIOP2-S | 3.841 |
| acarbose | 2306.018 |
Figure 7Evaluation of the cytotoxicity of HIOP1-S and HIOP2-S on HepG2 cells (A) at 48 h and (B) 72 h.
Figure 8Effects of HIOP1-S and HIOP2-S on the glucose consumption of HepG2 cells. ** p < 0.01, DC vs. NC; & p < 0.01, HIOP1-S (20 μg/mL) vs. HIOP1-S (10 and 40 μg/mL); # p < 0.01, HIOP2-S (20 μg/mL) vs. HIOP2-S (10 and 40 μg/mL); and $ p < 0.05, HIOP2-S (20 μg/mL) vs. HIOP1-S (20 μg/mL). The data are expressed as the means ± SD.
Effect of HIOP1-S and HIOP2-S on the fasting blood glucose levels of Streptozotocin-induced diabetic mice.
| Groups | Numbers | Dose (mg/kg bw) | Blood Glucose (mmol L−1) | |||
|---|---|---|---|---|---|---|
| 0 day | 7 days | 14 days | 21 days | |||
| Blank control | 12 | 0 | 7.74 ± 5.30 | 8.72 ± 1.24 | 9.96 ± 1.8 | 9.70 ± 1.70 |
| Model group | 12 | 0 | 19.02 ± 7.05 * | 22.81 ± 2.02 | 34.25 ± 1.94 | 19.50 ± 1.86 |
| Met | 12 | 125 | 19.95 ± 6.23 * | 18.24 ± 3.95 ** | 25.92 ± 5.98 ** | 16.62 ± 3.2 ** |
| HIOP1-S | 12 | 4.5 | 18.24 ± 7.49 * | 21.79 ± 5.02 | 28.04 ± 7.32 | 18.35 ± 3.02 |
| HIOP2-S | 12 | 4.5 | 18.53 ± 7.21 * | 18.59 ± 7.69 | 28.25 ± 10.78 | 14.9 ± 5.26 ** |
Means ± S.D.; bw, body weight. * p < 0.05 vs. Normal control group. ** p < 0.05 vs. Diabetic control group.
Effects of HIOP1-S and HIOP2-S on the body weights of STZ-induced diabetic mice.
| Groups | Numbers | Dose (mg/kg) | bw/g | |||
|---|---|---|---|---|---|---|
| 0 day | 7 days | 14 days | 21 days | |||
| Blank control | 12 | 0 | 24.89 ± 1.35 | 30.05 ± 2.87 | 32.23 ± 2.83 | 34.84 ± 2.87 |
| Model group | 12 | 0 | 23.41 ± 1.78 | 25.15 ± 1.73 * | 27.51 ± 1.92 * | 29.22 ± 2.55 * |
| Met | 12 | 125 | 24.41 ± 1.63 | 26.75 ± 2.01 * | 28.39 ± 2.15 * | 30.25 ± 2.74 * |
| HIOP1-S | 12 | 4.5 | 24.50 ± 2.39 | 27.58 ± 2.34 * | 28.29 ± 2.38 * | 28.41 ± 2.61 * |
| HIOP2-S | 12 | 4.5 | 23.95 ± 1.69 | 25.59 ± 3.29 * | 26.97 ± 2.75 * | 28.31 ± 2.92 * |
Mean ± S.D.; bw, body weight. * p < 0.05 vs. Normal control group.